USPTO serial 79224197
ENZYNOMICS
Reviewed by CopyMark Law Group
Reg. 5651935Status 707Registered
- Filing date
- Status date
- Registration date
- Jan 15, 2019
- Examiner
- SEVERSON, JUSTIN
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with ENZYNOMICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jun-Hwa Jeong
Jun-Hwa Jeong RABIN & BERDO, P.C.2650 Park Tower Drive, Suite 800Vienna, VA 22180United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Enzyme for scientific or laboratory purposes; [ marker for analyzing proteins for scientific or laboratory purposes; reagent for analyzing proteins for scientific or laboratory purposes; chemical analysis kits for analyzing proteins for scientific or laboratory purposes; protease for scientific or laboratory purposes; protein preparation for scientific or laboratory purposes; protein synthetase for scientific or laboratory purposes; biological preparation for use in cell cultures for scientific or laboratory purposes; cells for scientific or laboratory purposes; fluorescent dye for scientific or laboratory purposes; preparation specify type of preparation for genetic recombination for scientific or laboratory purposes; recombinant nucleic acid for scientific or laboratory purposes; ] marker for analyzing nucleic acid for scientific or laboratory purposes; ligase for scientific or laboratory purposes; [ plasmid for scientific or laboratory purposes; fluorescent dye for analyzing nucleic acid for scientific or laboratory purposes; protein for scientific or laboratory purposes; chemicals for genetic recombination for scientific or laboratory purposes; ] recombinant protein for scientific or laboratory purposes; enzymes for nucleic acid amplifications for scientific or laboratory purposes; [ cultures of microorganisms for transformation for scientific or laboratory purposes; fluorescent dye for analyzing proteins for scientific or laboratory purposes; reagent for extracting proteins for scientific or laboratory purposes; cultures of microorganisms for scientific or laboratory purposes; ] restriction enzyme for scientific or laboratory purposes; chemical reagent for scientific or laboratory purposes; nuclease for scientific or laboratory purposes; [ nucleic acid for scientific or laboratory purposes; ] reagent for analyzing nucleic acid for scientific or laboratory purposes; chemical for analyzing nucleic acid for scientific or laboratory purposes; [ preparations for nucleic acid for scientific or laboratory purposes; ] reagent for nucleic acid amplifications for scientific or laboratory purposes; [ reagent for extracting nucleic acid for scientific or laboratory purposes; ] enzyme for synthesizing nucleic acid for scientific or laboratory purposes | ACTIVE | — |
| 005 | [Chemical reagent for analyzing proteins for medical or veterinary purposes; pharmaceutical preparations for analyzing proteins for medical or veterinary purposes; chemical reagent for extracting proteins for medical or veterinary purposes; protein for medical or veterinary purposes; cultures of microorganism for medical or veterinary purposes; dye for medical or veterinary purposes;] pharmaceutical preparations for gene recombination for medical or veterinary purposes; recombinant protein for medical or veterinary purposes; restriction enzyme for medical or veterinary purposes; plasmid for medical or veterinary purposes; nucleic acid for medical or veterinary purposes; preparation for nucleic acid for medical or veterinary purposes; marker for analyzing proteins for medical or veterinary purposes; protein synthetase for medical or veterinary purposes; preparations for genetic recombination for medical or veterinary purposes; marker for analyzing nucleic acid for medical or veterinary purposes; pharmaceutical for analyzing nucleic acid for medical or veterinary purposes; biological preparation for medical or veterinary purposes; cells for medical or veterinary purposes; recombinant nucleic acid for medical or veterinary purposes; chemical reagent for analyzing nucleic acid for medical or veterinary purposes; chemical reagent for extracting nucleic acid for medical or veterinary purposes; protease for medical or veterinary purposes; ligase for medical or veterinary purposes; protein preparation for medical or veterinary purposes; chemical reagent for nucleic acid amplifications for medical or veterinary purposes; dye for analyzing nucleic acid for medical or veterinary purposes; nuclease for medical or veterinary purposes; enzyme for nucleic acid amplifications for medical or veterinary purposes; enzyme for synthesizing nucleic acid for medical or veterinary purposes; cultures of microorganism for transformation for medical or veterinary purposes; chemical reagent for medical or veterinary purposes; enzymes for medical or veterinary purpose] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Enzynomics Co. Ltd.
- Other trademarks owned by Enzynomics Co. Ltd.
- Other trademarks owned by Enzynomics Co. Ltd.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named ENZYNOMICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 30, 2026 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jan 30, 2026 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Aug 11, 2025 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Dec 11, 2024 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Dec 11, 2024 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Dec 2, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 25, 2024 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Jan 15, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jan 8, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 17, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 1, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 30, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 15, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 15, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 15, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 2, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 30, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 30, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 25, 2018 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Oct 10, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 10, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 10, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 19, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 19, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 19, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 19, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 19, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 14, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 14, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 14, 2018 | ALIE | ASSIGNED TO LIE | — |
| Sep 5, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 24, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 5, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 5, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 27, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 26, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 20, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 12, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 8, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 4, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |